Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects-Reference-Cited by-同舟云学术

Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects

Published:2012-01 Issue:1 Volume:20 Page:230-238
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Yannaki Evangelia,Papayannopoulou Thalia,Jonlin Erica,Zervou Fani,Karponi Garyfalia,Xagorari Angeliki,Becker Pamela,Psatha Nikoleta,Batsis Ioannis,Kaloyannidis Panayotis,Tahynopoulou Varvara,Constantinou Varnavas,Bouinta Asimina,Kotta Konstantia,Athanassiadou Aglaia,Anagnostopoulos Achilles,Fassas Athanasios,Stamatoyannopoulos George

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference37 articles.

1. The biology and clinical uses of blood stem cells;To;Blood,1997

2. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT);Champlin;Blood,2000

3. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers;Bensinger;N Engl J Med,2001

4. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program;Miller;Biol Blood Marrow Transplant,2008

5. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor;Falzetti;Lancet,1999

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors;2023-10-06

2. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies;JCI Insight;2022-10-10

3. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo;Blood;2021-10-28

4. Red blood cell reduction of a sickle cell disease stem cell product;Transfusion;2021-08-29

5. Therapy Development by Genome Editing of Hematopoietic Stem Cells;Cells;2021-06-14